drugset / Trial / NCT00136058
Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients
Phase 3
Completed
250 enrolled
University of Alberta
Alberta Heritage Foundation for Medical Research · collab
RandomizedParallel-groupOpen-label
Summary
The objective of this study is to determine if an intervention with a fracture manager to arrange bone densitometry after a hip fracture is more effective in diagnosing and treating osteoporosis when compared to "usual care". "Usual care" consists of no intervention to arrange bone mineral density (BMD) testing or therapy other than what normally occurs in the community. The investigators postulate that a fracture manager will be more effective in getting BMD done and in starting appropriate therapy.
Timeline
- Start
- 2002-01
- Primary completion
- —
- Completion
- 2006-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alendronic Acid | Small molecule | — | — |
| Subject | Risedronate | Small molecule | — | — |